• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,550.25 918.60
( 1.20%)
Global Indices
Nasdaq
47,930.49 -276.32
(-0.57%)
Dow Jones
6,837.38 -8.28
(-0.12%)
Hang Seng
56,916.27 1,020.95
(1.83%)
Nikkei 225
10,596.33 -7.15
(-0.07%)
Forex
USD-INR
92.50 0.06
(0.07%)
EUR-INR
108.05 0.09
(0.08%)
GBP-INR
124.08 0.03
(0.03%)
JPY-INR
0.58 0.00
(-0.25%)

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524636
INE102E01018
-9.9177201
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
207.33
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

amerise biosciences ltd
NTPC rises after signing MoU with EDF for nuclear power projects
Apr 09,2026
The MoU establishes a framework for both companies to jointly assess the feasibility and approach for collaboration, including understanding EDF’s EPR technology and its suitability for Indian requirements; exploring opportunities to maximize localization for large-scale deployment; examining economic and tariff aspects; developing human resource capabilities through training programs; evaluating potential project sites; and providing technical support as mutually agreed.

“This initiative aligns with NTPC’s strategy to expand into clean, reliable energy and contribute to India’s long-term energy security,” the company said in a statement.

NTPC, along with its subsidiaries/associates & JVs, is primarily involved in the generation and sale of bulk power to state power utilities. Other business of the group includes providing consultancy, project management & supervision, energy trading, oil & gas exploration, and coal mining.

The company reported an 8.27% increase in consolidated net profit to Rs 5,597.05 crore, supported by a 1.72% rise in net sales to Rs 45,845.68 crore in Q3 FY26 over Q3 FY25.